DOHOAXZXXYIQHA-SOUVJXGZSA-N
Compound with spectra: 2 NMR
| SpectraBase Compound ID | B0NfaDjsjpG |
|---|---|
| InChI | InChI=1S/C18H25NO5/c1-4-24-18(21)13-8-14-12-9-17(23-3)16(22-2)7-11(12)5-6-19(14)10-15(13)20/h7,9,13-15,20H,4-6,8,10H2,1-3H3/t13-,14-,15+/m0/s1 |
| InChIKey | DOHOAXZXXYIQHA-SOUVJXGZSA-N |
| Mol Weight | 335.4 g/mol |
| Molecular Formula | C18H25NO5 |
| Exact Mass | 335.173273 g/mol |
| Enantiomer InChIKey | DOHOAXZXXYIQHA-KFWWJZLASA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|
- ETHYL-(9,10-DIMETHOXY-3-BETA-HYDROXY-1,2,4,6,7,11B-ALPHA-HEXAHYDRO-3H-BENZO-[A]-QUINOLIZIN-2-BETA-YL)-CARBOXYLATE
ETHYL-(9,10-DIMETHOXY-3-BETA-HYDROXY-1,2,4,6,7,11B-ALPHA-HEXAHYDRO-3H-BENZO-[A]-QUINOLIZIN-2-ALPHA-YL)-CARBOXYLATE
ETHYL-(9,10-DIMETHOXY-3-ALPHA-HYDROXY-1,2,4,6,7,11B-ALPHA-HEXAHYDRO-3H-BENZO-[A]-QUINOLIZIN-2-ALPHA-YL)-CARBOXYLATE
ETHYL-(9,10-DIMETHOXY-3-ALPHA-HYDROXY-1,2,4,6,7,11B-ALPHA-HEXAHYDRO-3H-BENZO-[A]-QUINOLIZIN-2-BETA-YL)-CARBOXYLATE
2H-Benzo[a]quinolizine-2-acetic acid, 3-ethyl-.alpha.-formyl-1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-, methyl ester
Emetine ME
Benzquinamide HY
JBBRFTTWPDEIQH-LXZKKBNFSA-N
OMTAUJXNTVYFSV-LXZKKBNFSA-N
10-Benzyloxy-2,3-dimethoxy-5,8,13,13a-tetrahydro-6H-isoquino[3,2-a]isoquinoline
ETHYL 3-[9,10-DIMETHOXY-2-OXO-1,3,4,6,7,11B-ALPHA-HEXAHYDRO-2H-BENZO[A]QUINOLIZIN-(1BETA)-YL]PROPIONATE
| Title | Journal or Book | Year |
|---|---|---|
| Synthesis and Phermacodynamic Investigation of New Isoguvacine Analogues with Benzoquinolizine Skeleton | HETEROCYCLES | 1986 |
This compound is available in the following databases:
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.